Fan et al. also reported that combination therapy with atorvastatin and low-dose dexamethasone counteracted hematoma-induced Kruppel-like factor-2 suppression in human cerebral endothelial cells, thus reducing endothelial inflammation and permeability [26]. This evidence concerns the gene KLF2 and hematoma.